Wang Zhi-Long, Chen Ying, Li Xiao-Ting, Chen Ke-Neng, Sun Ying-Shi
From the Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology (Z-LW, YC, X-TL, Y-SS); and Department of Thoracic Surgery (K-NC), Peking University Cancer Hospital and Institute, Haidian District, Beijing, China.
Medicine (Baltimore). 2016 May;95(18):e3583. doi: 10.1097/MD.0000000000003583.
In this study, we evaluated the efficacy of baseline computed tomography (CT) signs and postoperative TN stages on survival of patients with advanced esophageal squamous cell carcinoma with preoperative chemotherapy. Consecutive patients (n = 130) with preoperative chemotherapy and radical esophagectomy from January 2006 to December 2011 were enrolled in this study retrospectively. Pathological T and N stages were confirmed by surgery. Baseline CT signs of tumor length, tumor thickness, outer membrane features, total number of lymph node (tLN), short diameter of the largest lymph node (SDL), and clinical T and N stages were measured. Eight-year overall survival (OS) and disease-free survival (DFS) were estimated using Kaplan-Meier and Cox proportional hazards regression analyses to determine associations between baseline CT signs and survival outcomes. Kaplan-Meier analysis showed that tLN number, largest LN short axis diameter, pT, and pN stages all correlated with OS significantly. And the total tLN number, SDL and pN stages significantly correlated with DFS. In Cox analyses, total tLN number (>6) and pN stage were significantly associated with OS (hazard ratio [HR]: 1.55 [95% CI, 1.13-2.11, P = 0.006] and HR: 1.49 [95% CI, 1.17-1.90, P = 0.001], respectively). Cox regression analysis showed that OS index was predictive of 1- to 3-year survival. Total number of lymph node in baseline CT provides equal efficiency compared to pN stages in the prediction of 8-year long-term survival outcomes for advanced esophageal squamous cell carcinoma patients with preoperative chemotherapy.
在本研究中,我们评估了基线计算机断层扫描(CT)征象及术后TN分期对接受术前化疗的晚期食管鳞状细胞癌患者生存情况的影响。本研究对2006年1月至2011年12月期间接受术前化疗并接受根治性食管切除术的连续患者(n = 130)进行了回顾性分析。手术确定病理T和N分期。测量肿瘤长度、肿瘤厚度、外膜特征、淋巴结总数(tLN)、最大淋巴结短径(SDL)等基线CT征象以及临床T和N分期。采用Kaplan-Meier法和Cox比例风险回归分析评估8年总生存(OS)率和无病生存(DFS)率,以确定基线CT征象与生存结局之间的关联。Kaplan-Meier分析显示,tLN数量、最大淋巴结短轴直径、pT和pN分期均与OS显著相关。tLN总数、SDL和pN分期与DFS显著相关。在Cox分析中,tLN总数(>6)和pN分期与OS显著相关(风险比[HR]分别为1.55[95%CI,1.13 - 2.11,P = 0.006]和HR:1.49[95%CI,1.17 - 1.90,P = 0.001])。Cox回归分析显示,OS指数可预测1至3年生存情况。对于接受术前化疗的晚期食管鳞状细胞癌患者,基线CT中的淋巴结总数在预测8年长期生存结局方面与pN分期具有同等效率。